McKesson Corp. Price Target Increased to $150.00 by Analysts at Robert W. Baird (MCK)
Research analysts at Robert W. Baird hoisted their price objective on shares of McKesson Corp. (NYSE:MCK) from $135.00 to $150.00 in a report released on Tuesday, ARN reports. The firm currently has an “outperform” rating on the stock. Robert W. Baird’s target price suggests a potential upside of 14.05% from the stock’s previous close.
MCK has been the subject of a number of other recent research reports. Analysts at UBS AG raised their price target on shares of McKesson Corp. (NYSE:MCK) from $127.00 to $143.00 in a research note to investors on Wednesday, September 25th. They now have a “buy” rating on the stock. Separately, analysts at Sterne Agee initiated coverage on shares of McKesson Corp. (NYSE:MCK) in a research note to investors on Wednesday, September 18th. They set a “buy” rating and a $164.00 price target on the stock. Finally, analysts at Zacks upgraded shares of McKesson Corp. (NYSE:MCK) from a “neutral” rating to an “outperform” rating in a research note to investors on Monday, August 5th. They now have a $148.00 price target on the stock. Two research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average price target of $132.25.
Shares of McKesson Corp. (NYSE:MCK) traded up 2.51% during mid-day trading on Tuesday, hitting $131.52. 1,264,753 shares of the company’s stock traded hands. McKesson Corp. has a 1-year low of $85.57 and a 1-year high of $133.33. The stock’s 50-day moving average is $125.3 and its 200-day moving average is $116.4. The company has a market cap of $30.069 billion and a P/E ratio of 22.04.
McKesson Corp. (NYSE:MCK) last posted its quarterly earnings results on Thursday, July 25th. The company reported $2.07 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.71 by $0.36. The company had revenue of $32.20 billion for the quarter, compared to the consensus estimate of $32.60 billion. During the same quarter in the previous year, the company posted $1.55 earnings per share. The company’s revenue for the quarter was up 4.9% on a year-over-year basis. On average, analysts predict that McKesson Corp. will post $8.31 earnings per share for the current fiscal year.
McKesson Corporation delivers pharmaceuticals, medical supplies and healthcare information technologies.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.